日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effective allogeneic natural killer cell therapy for pancreatic adenocarcinoma avails conserved activating receptors and evades HLA I-driven inhibition

针对胰腺腺癌的有效同种异体自然杀伤细胞疗法利用了保守的激活受体,并逃避了HLA I驱动的抑制。

Lee, Stacey N; Arseneau, Riley J; Arnason, Thomas; Boudreau, Jeanette E

Cecal microbiota and Clostridium perfringens in broilers fed barley-based diets: Effects of enzyme supplementation and degree of grinding

以大麦为基础日粮的肉鸡盲肠微生物群和产气荚膜梭菌:酶补充剂和研磨程度的影响

Estensmo, Eva Lena; Sekse, Camilla; Steinhoff, Franciska S; Ljøkjel, Kari; Itani, Khaled; Ahmad, Muhammad; Bøe, Cathrine Arnason; Sjurseth, Siri Kulberg; Granstad, Silje

Variant in a Taste Receptor Locus Tied to Changes in the Use of Insomnia Medication

味觉受体基因位点的变异与失眠药物使用方式的改变有关

Einarsson, Gudmundur; Arnason, Hannes K; Gisladottir, Rosa S; Bjornsdottir, Gyda; Thorgeirsson, Thorgeir E; Skuladottir, Astros; Walters, G Bragi; Saevarsdottir, Saedis; Magnusson, Magnus K; Halldorsson, Gisli H; Snaebjarnarson, Audunn S; Einarsson, Hafsteinn; Sveinbjornsson, Gardar; Helgason, Hannes; Tragante, Vinicius; Jonsdottir, Gudrun A; Aegisdottir, Hildur M; Jonsdottir, Ingileif; Gislason, Thorarinn; Thorleifsson, Gudmar; Sulem, Patrick; Stefansson, Hreinn; Gudbjartsson, Daniel F; Stefansson, Kari

Preoperative Soluble AXL in Plasma Predicts Futility of Resecting Pancreatic Ductal Adenocarcinoma

术前血浆中可溶性AXL水平可预测胰腺导管腺癌切除术的无效性

Samson, Thomas; Aali, Maral; McBride, Darien; Arnason, Thomas; Clarke, Sharon E; Ramjeesingh, Ravi; Gonzalez-Chavez, Lisette; Azizieh, Yara; Walsh, Mark J; Livingstone, Scott M; Hiebert, Stephanie E; Boudreau, Jeanette E; Gala-Lopez, Boris L

Highly Pathogenic Avian Influenza A (H5N1) Caused Mass Death Among Black-Legged Kittiwakes (Rissa tridactyla) in Norway, 2023

2023年,高致病性禽流感A型(H5N1)导致挪威黑腿三趾鸥(Rissa tridactyla)大量死亡。

Rømo, Grim; Åkesson, Caroline Piercey; Reiertsen, Tone Kristin; Fosse, Johanna Hol; Bøe, Cathrine Arnason; Austbø, Lars; Åkerstedt, Johan; Saghafian, Maryam; Helberg, Morten; Hungnes, Olav; Gjerset, Britt; Granstad, Silje; Hogseth, Gørill; Løtvedt, Siri; Døsen, Anne; Tønnessen, Ragnhild

Evaluation of Novel Dillapiol Analogs as Insect Detoxification Enzyme Inhibitors and Insecticide Synergists

新型二氢槲皮素类似物作为昆虫解毒酶抑制剂和杀虫剂增效剂的评价

Liu, Suqi; Carballo-Arce, Ana Francis; Wang, Zhiling; Durst, Tony; Sims, Steven R; Arnason, John T; Scott, Ian M

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

Lisocabtagene Maraleucel Versus Standard of Care for Second-Line Relapsed/Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From the Randomized, Phase III TRANSFORM Study

利索卡巴他根马拉鲁塞与二线复发/难治性大B细胞淋巴瘤标准治疗方案对比:来自随机III期TRANSFORM研究的3年随访结果

Kamdar, Manali; Solomon, Scott R; Arnason, Jon; Johnston, Patrick B; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Chow, Victor A; Montheard, Sandrine; Santamaria, Josu; Colicino, Silvia; Ogasawara, Ken; Stepan, Lara; Liu, Fei Fei; Abramson, Jeremy S

Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study

奥德罗内西他单药治疗CAR-T细胞疗法进展后的复发/难治性弥漫性大B细胞淋巴瘤:ELM-1研究的主要分析

Topp, Max S; Matasar, Matthew; Allan, John N; Ansell, Stephen M; Barnes, Jeffrey A; Arnason, Jon E; Michot, Jean-Marie; Goldschmidt, Neta; O'Brien, Susan M; Abadi, Uri; Avivi, Irit; Cheng, Yuan; Flink, Dina M; Zhu, Min; Brouwer-Visser, Jurriaan; Chaudhry, Aafia; Mohamed, Hesham; Ambati, Srikanth; Crombie, Jennifer L

Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

伊布替尼联合乌布拉利西治疗复发/难治性慢性淋巴细胞白血病的1/1b期研究的长期结果

Ryan, Christine E; Ren, Yue; Tyekucheva, Svitlana; Arnason, Jon E; Boruchov, Adam M; Jacobson, Caron A; Fisher, David C; Miskin, Hari; Sportelli, Peter; Brown, Jennifer R; Davids, Matthew S